Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pyxis Oncology
Biotech
Longtime Takeda R&D chief to depart next June—Chutes & Ladders
Longtime Takeda R&D chief to depart next June. Sofinnova lands Gilead alum as executive partner. Pyxis locks in interim CEO before phase 1 results.
Donavyn Coffey
,
Marissa Russo
,
Will Maddox
Sep 11, 2026 8:30am
Biopharma veteran takes her CEO Cue—Chutes & Ladders
May 8, 2026 8:30am
Moderna CMO steps down in leadership mix-up—Chutes & Ladders
Feb 6, 2026 8:30am
Pyxis lays off 20% of staff to swing behind single-candidate strategy
Mar 18, 2025 9:00am
Pyxis whittles pipeline down to one clinical asset
Dec 20, 2024 6:15am
Pyxis' shares fall on lukewarm early ADC results in solid tumors
Nov 21, 2024 2:30pm